OPKO Health Receives U.S. Patent Allowance
OPKO Health, Inc. (NYSE: OPK) today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled “Flow Control in Microfluidic Systems”.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.